Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gansu Chenland Biological Technology is a specialized biotechnology company focused on the development and manufacturing of peptides and amino acid derivatives. Headquartered in Lanzhou, China, the company serves as a key supplier of pharmaceutical intermediates and provides custom synthesis services for the global pharmaceutical industry. Their expertise lies in large-scale peptide production, including protected amino acids and reagents essential for synthesizing GLP-1 receptor agonists. The company operates modern research and production facilities designed to meet international quality standards for drug development. By providing critical building blocks for metabolic and endocrine therapies, Chenland supports both early-stage research and commercial-scale manufacturing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gansu Chenland Biological Technology.